BeOne Medicines (BEIGF) FCF Margin (2015 - 2026)
BeOne Medicines (BEIGF) reported FCF Margin of 10.45% for Q1 2026, up 1187.0% year-over-year from 0.81% in Q1 2025, and down 44.81% quarter-over-quarter from 18.93% in Q4 2025.
BeOne Medicines (BEIGF) FCF Margin (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of FCF Margin data on file, last reported at 10.45% in Q1 2026.
- FCF Margin for Q1 2026 came in at 10.45%, up 1187.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 19.44% (up 1373.0% YoY), and the FY2025 annual result was 17.63%, up 2316.0% from the prior year.
- FCF Margin fell to 10.45% in Q1 2026 per BEIGF's latest filing, from 18.93% in the prior quarter.
- Over five years, FCF Margin peaked at 35.91% in Q4 2024 and troughed at 172.99% in Q3 2022.
- A 5-year average of 45.54% and a median of 22.12% in 2024 frame the typical range for FCF Margin.
- On a YoY basis, FCF Margin climbed as much as 18758 bps in 2022 and fell as far as 21932 bps in 2022.
- A 5-year view of FCF Margin shows it stood at 115.64% in 2022, then rose by 8 bps to 106.54% in 2023, then jumped by 134 bps to 35.91% in 2024, then plunged by 47 bps to 18.93% in 2025, then plunged by 45 bps to 10.45% in 2026.
- Business Quant data shows BEIGF's FCF Margin at 10.45% in Q1 2026, 18.93% in Q4 2025, and 28.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 10.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.45% |
| Dec 31, 2025 | 18.93% |
| Sep 30, 2025 | 28.92% |
| Jun 30, 2025 | 20.20% |
| Mar 31, 2025 | -1.43% |
| Dec 31, 2024 | 35.91% |
| Sep 30, 2024 | 5.46% |
| Jun 30, 2024 | -22.12% |
| Mar 31, 2024 | -44.97% |
| Dec 31, 2023 | -106.54% |
| Sep 30, 2023 | 7.85% |
| Jun 30, 2023 | -80.12% |
| Mar 31, 2023 | -140.19% |
| Dec 31, 2022 | -115.64% |
| Sep 30, 2022 | -172.99% |
| Jun 30, 2022 | -125.96% |
| Mar 31, 2022 | -91.87% |
| Dec 31, 2021 | 103.68% |
| Sep 30, 2021 | -272.60% |
| Jun 30, 2021 | -313.54% |